AAAAAA
Results:
1-13
|
Results: 13
Authors:
Martinowitz, U
Kenet, G
Segal, E
Luboshitz, J
Lubetsky, A
Ingerslev, J
Lynn, M
Citation: U. Martinowitz et al., Recombinant activated factor VII for adjunctive hemorrhage control in trauma, J TRAUMA, 51(3), 2001, pp. 431-438
Authors:
Luboshitz, J
Lubetsky, A
Schliamser, L
Kotler, A
Tamarin, I
Inbal, A
Citation: J. Luboshitz et al., Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome, THROMB HAEM, 85(5), 2001, pp. 806-809
Authors:
Seligsohn, U
Lubetsky, A
Citation: U. Seligsohn et A. Lubetsky, Thrombophilia - Reply, N ENG J MED, 345(9), 2001, pp. 698-699
Authors:
Seligsohn, U
Lubetsky, A
Citation: U. Seligsohn et A. Lubetsky, Medical progress: Genetic susceptibility to venous thrombosis., N ENG J MED, 344(16), 2001, pp. 1222-1231
Authors:
Loebstein, R
Yonath, H
Peleg, D
Almog, S
Rotenberg, M
Lubetsky, A
Roitelman, J
Harats, D
Halkin, H
Ezra, D
Citation: R. Loebstein et al., Interindividual variability in sensitivity to warfarin - Nature or nurture?, CLIN PHARM, 70(2), 2001, pp. 159-164
Authors:
Kenet, G
Lubetsky, A
Gitel, S
Luboshitz, J
Varon, D
Martinowitz, U
Citation: G. Kenet et al., Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII, BL COAG FIB, 11, 2000, pp. S35-S38
Authors:
Salomon, O
Steinberg, DM
Zivelin, A
Gitel, S
Dardik, R
Rosenberg, N
Berliner, S
Inbal, A
Many, A
Lubetsky, A
Varon, D
Martinowitz, U
Seligsohn, U
Citation: O. Salomon et al., Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism - Prevalence and risk assessment, ART THROM V, 19(3), 1999, pp. 511-518
Authors:
Lubetsky, A
Dekel-Stern, E
Chetrit, A
Lubin, F
Halkin, H
Citation: A. Lubetsky et al., Vitamin K intake and sensitivity to warfarin in patients consuming regulardiets, THROMB HAEM, 81(3), 1999, pp. 396-399
Authors:
Lubetsky, A
Schulman, S
Varon, D
Martinowitz, U
Kenet, G
Gitel, S
Inbal, A
Citation: A. Lubetsky et al., Safety and efficacy of continuous infusion of a combined factor VIII - vonWillebrand factor (vWF) concentrate (Haemate-P (TM)) in patients with von Willebrand disease, THROMB HAEM, 81(2), 1999, pp. 229-233
Authors:
Hayek, S
Kenet, G
Lubetsky, A
Rosenberg, N
Gitel, S
Wientroub, S
Citation: S. Hayek et al., Does thrombophilia play arm aetiological role in Legg-Calve-Perthes disease?, J BONE-BR V, 81B(4), 1999, pp. 686-690
Authors:
Halkin, H
Lubetsky, A
Citation: H. Halkin et A. Lubetsky, Warfarin dose requirement and CYP2C9 polymorphisms, LANCET, 353(9168), 1999, pp. 1972-1972
Authors:
Lubetsky, A
Winaver, J
Seligmann, H
Olchovsky, D
Almog, S
Halkin, H
Ezra, D
Citation: A. Lubetsky et al., Urinary thiamine excretion in the rat: Effects of furosemide, other diuretics, and volume load, J LA CL MED, 134(3), 1999, pp. 232-237
Authors:
Rieck, J
Halkin, H
Almog, S
Seligman, H
Lubetsky, A
Olchovsky, D
Ezra, D
Citation: J. Rieck et al., Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers, J LA CL MED, 134(3), 1999, pp. 238-243
Risultati:
1-13
|